ImmunoBiochem has attended RESI in Toronto for investor meetings and exhibited at The Future of Health Innovation during the Toronto Health Innovation Week (THIW)
The Future of Health Innovation at MaRS Discovery District
ImmunoBiochem's CEO, Anton Neschadim, speaking at the RESI "Tales from the Road" CEO Panel

ImmunoBiochem enters into a collaboration with another JLABS company, Advanced Proteome Therapeutics, to develop improved ADCs
Joint News Release

ImmunoBiochem is one of the winners at the RESI Innovation Challenge during the 2018 JPM Healthcare Conference Week in San Francisco
RESI News Release

ImmunoBiochem Corporation announces the completion of a new round of financing and residency at Johnson & Johnson Innovation, JLABS @ Toronto.
ImmunoBiochem Press Release
Download PDF

ImmunoBiochem Corporation is accepted into the Ontario Bioscience Innovation Organization (OBIO) Capital Access Advisory Program (CAAP) 2017 cohort.
OBIO Press Release

ImmunoBiochem Corporation is a finalist in the upcoming MaRS HealthKick Innovation Challenge at the RESI Conference on June 23rd.
MaRS HealthKick Innovation Challenge @RESI

ImmunoBiochem Corporation partners with the Centre for the Commercialization of Antibodies and Biologics at the University of Toronto to advance new Antibody Drug Conjugates.
ImmunoBiochem Press Release
Download PDF

ImmunoBiochem and York University Embark on a New Target Discovery Partnership.
York University Press Release

ImmunoBiochem is a semi-finalist at the OneStart 2015 Competition, organised by SR One and the Oxbridge Biotech Roundtable (OBR).
OneStart 2015 Semi-Finalists Announced